PL334806A1 - Aminobenzophenones as inhibitors of interleukin and tnf - Google Patents

Aminobenzophenones as inhibitors of interleukin and tnf

Info

Publication number
PL334806A1
PL334806A1 PL98334806A PL33480698A PL334806A1 PL 334806 A1 PL334806 A1 PL 334806A1 PL 98334806 A PL98334806 A PL 98334806A PL 33480698 A PL33480698 A PL 33480698A PL 334806 A1 PL334806 A1 PL 334806A1
Authority
PL
Poland
Prior art keywords
alkyl
content
carbamoyl
alkoxycarbonyl
trifluoromethyl
Prior art date
Application number
PL98334806A
Other languages
English (en)
Inventor
Erik Rytter Ottosen
Schneur Rachlin
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of PL334806A1 publication Critical patent/PL334806A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL98334806A 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and tnf PL334806A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9701453.4A GB9701453D0 (en) 1997-01-24 1997-01-24 Aminobenzophenones
PCT/DK1998/000008 WO1998032730A1 (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and tnf

Publications (1)

Publication Number Publication Date
PL334806A1 true PL334806A1 (en) 2000-03-13

Family

ID=10806523

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98334806A PL334806A1 (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and tnf

Country Status (19)

Country Link
US (1) US6313174B1 (https=)
EP (1) EP0966424B1 (https=)
JP (1) JP4250204B2 (https=)
KR (1) KR100544046B1 (https=)
CN (1) CN1188388C (https=)
AT (1) ATE269844T1 (https=)
AU (1) AU733561B2 (https=)
CA (1) CA2278798C (https=)
DE (1) DE69824705T2 (https=)
DK (1) DK0966424T3 (https=)
ES (1) ES2223116T3 (https=)
GB (1) GB9701453D0 (https=)
HU (1) HUP0000678A3 (https=)
NZ (1) NZ336754A (https=)
PL (1) PL334806A1 (https=)
PT (1) PT966424E (https=)
RO (1) RO120195B1 (https=)
RU (1) RU2200153C2 (https=)
WO (1) WO1998032730A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1210325B1 (en) 1999-07-16 2004-10-06 Leo Pharma A/S Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
RU2240995C2 (ru) * 1999-07-16 2004-11-27 Лео Фармасьютикал Продактс Лтд.А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) Аминобензофеноны в качестве ингибиторов интерлейкина il-1бета и фактора некроза опухолей tnf-альфа
AU768473B2 (en) * 1999-07-16 2003-12-11 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel aminobenzophenones
US6897236B1 (en) 1999-07-16 2005-05-24 Leo Pharmaceutical Products, Ltd. Aminobenzophenones as inhibitors of IL-1β and TNF-α
ES2228555T3 (es) * 1999-07-16 2005-04-16 Leo Pharma A/S Aminobenzofenonas con inhibidores de la il-1beta y tnf-alfa.
ATE277889T1 (de) * 1999-07-16 2004-10-15 Leo Pharma As Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
MXPA02005604A (es) * 1999-12-06 2004-09-10 Leo Pharma As Aminobenzofenonas como inhibidores de il-1beta y tnf-alfa.
CA2393027A1 (en) * 1999-12-17 2001-06-21 Abbott Laboratories Inhibitors of interleukin 5 gene expression
CA2394727A1 (en) * 1999-12-28 2001-07-05 Pharmacopeia, Inc. Pyrimidine and triazine kinase inhibitors
AU2001260081B2 (en) 2000-05-22 2005-07-28 Leo Pharma A/S Benzophenones as inhibitors of il-1beta and tnf-alpha
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
SE0100569D0 (sv) * 2001-02-20 2001-02-20 Astrazeneca Ab New compounds
GB0107368D0 (en) * 2001-03-23 2001-05-16 Novartis Ag Organic compounds
US20030073832A1 (en) * 2001-04-10 2003-04-17 Havez Sophie Elisabeth Novel aminophenyl ketone derivatives
KR100896667B1 (ko) * 2001-08-28 2009-05-14 레오 파마 에이/에스 신규한 아미노벤조페논 및 이를 포함하는 약제학적 조성물
PL377377A1 (pl) * 2002-12-20 2006-02-06 Leo Pharma A/S Nowe związki aminobenzofenonu
DK1658263T3 (da) * 2003-07-24 2010-09-27 Leo Pharma As Aminobenzophenonforbindelser
KR101260236B1 (ko) * 2004-12-13 2013-05-06 레오 파마 에이/에스 트리아졸 치환된 아미노벤조페논 화합물
DE102005022020A1 (de) * 2005-05-12 2006-11-23 Merckle Gmbh Dibenzocycloheptanverbindungen und pharmazeutische Mittel, welche diese Verbindungen enthalten
KR101057546B1 (ko) * 2007-06-05 2011-08-17 주식회사 엘지화학 광학 이방성 화합물 및 이를 포함하는 수지 조성물
EP2206534A1 (de) 2008-10-09 2010-07-14 c-a-i-r biosciences GmbH Dibenzocycloheptanonderivate und pharmazeutische Mittel, welche diese Verbindungen enthalten
WO2012167133A2 (en) * 2011-06-01 2012-12-06 The Regents Of The University Of California Inhibitors of anandamide transport and their therapeutic uses
WO2013028570A2 (en) 2011-08-19 2013-02-28 The Regents Of The University Of California Meta-substituted biphenyl peripherally restricted faah inhibitors
ES2908240T3 (es) 2014-04-07 2022-04-28 Univ California Inhibidores de la enzima amida hidrolasa de ácidos grasos (FAAH) con biodisponibilidad oral mejorada y su uso como medicamentos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1535401A (en) * 1977-07-28 1978-12-13 Holliday & Co Ltd L Nitrodiphenylamine carboxylic acid disperse dyes
SU790620A1 (ru) * 1979-06-01 1981-07-30 Ордена Трудового Красного Знамени Институт Медицинскойпаразитологии И Торпической Медицины Им.E.И.Марциновского Дихлор аминобензофенон как исходный продуктдл пОлучЕНи лЕКАРСТВЕННыХ пРЕпАРАТОВ C АНТигЕльМиНТНыМдЕйСТВиЕМ
JPH0776303B2 (ja) * 1986-11-21 1995-08-16 株式会社リコー 呈色性フタリド化合物及びその製造法及びこのものを発色成分とした記録材料

Also Published As

Publication number Publication date
JP2001511771A (ja) 2001-08-14
CN1248966A (zh) 2000-03-29
JP4250204B2 (ja) 2009-04-08
KR20000070437A (ko) 2000-11-25
CA2278798A1 (en) 1998-07-30
AU5478198A (en) 1998-08-18
GB9701453D0 (en) 1997-03-12
CN1188388C (zh) 2005-02-09
KR100544046B1 (ko) 2006-01-23
ATE269844T1 (de) 2004-07-15
ES2223116T3 (es) 2005-02-16
RO120195B1 (ro) 2005-10-28
US6313174B1 (en) 2001-11-06
WO1998032730A1 (en) 1998-07-30
HUP0000678A2 (hu) 2001-10-28
CA2278798C (en) 2007-07-03
PT966424E (pt) 2004-09-30
HK1025306A1 (en) 2000-11-10
NZ336754A (en) 2001-03-30
RU2200153C2 (ru) 2003-03-10
HUP0000678A3 (en) 2001-11-28
DE69824705T2 (de) 2005-07-07
EP0966424B1 (en) 2004-06-23
DE69824705D1 (de) 2004-07-29
AU733561B2 (en) 2001-05-17
EP0966424A1 (en) 1999-12-29
DK0966424T3 (da) 2004-11-01

Similar Documents

Publication Publication Date Title
PL334806A1 (en) Aminobenzophenones as inhibitors of interleukin and tnf
MY158162A (en) 5-membered heterocycle-based p38 kinase inhibitors
HU9303423D0 (en) Catechin-diether-type pdeiv-inhibitors
MXPA05013075A (es) Inhibidores de p-38 basados en heterociclo de 5 miembros.
MXPA05013224A (es) Piridinilcarbamatos como inhibidores de lipasa sensible a hormonas.
TR199801777T2 (xx) Triaril bile�ikler.
MY147449A (en) 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
YU6602A (sh) Pirimidin-2,4,6-trion metaloproteinazni inhibitori
PL1699800T3 (pl) Bicykliczne heterocykliczne inhibitory kinazy p-38
TW200510416A (en) P38 inhibitors and methods of use thereof
WO2005003099A3 (en) Pyrimidines useful as modulators of voltage-gated ion channels
TW200510311A (en) CCr8 inhibitors
MY109722A (en) Azaoxindole derivatives.
YU35699A (sh) 2-amino-6-(2-supstituisan-4-fenoksi)-supstituisani piridini
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
MY129491A (en) Hydrazono-malonitriles
TW200505865A (en) Compounds useful for the treatment of diseases
MXPA02011858A (es) Inhibidores de adhesion de celula mediada por alfabeta2.
AU2003278667A1 (en) Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
MXPA05010975A (es) Derivados de (6-(fenoxi)-pirido[3,4-d]pirimidin-2-il)-amina como inhibidores de p38 cinasa para el tratamiento de condiciones inflamatorias como artritis reumatoide.
BG108669A (bg) 2-амино-6-(2,4,5-заместени-фенил)-пиридини
TNSN05307A1 (en) 5-membered heterocycle-based p38 kinase inhibitors
SE0202279D0 (sv) Novel comppounds

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed